Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

15 Voluntary ex ante Transparency (VEAT) Notice

Blood glucose consumables and EQA materials

  • First published: 22 October 2021
  • Last modified: 22 October 2021
  • Record interest

     

  • This file may not be fully accessible.

  •  

Contents

Summary

OCID:
ocds-kuma6s-115133
Published by:
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Authority ID:
AA0221
Publication date:
22 October 2021
Deadline date:
-
Notice type:
15 Voluntary ex ante Transparency (VEAT) Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

Supply of blood glucose consumables (testing strips) and EQA materials. CPV: 33696200.

Full notice text

Voluntary ex ante transparency notice

Directive 2014/24/EU

Section I: Contracting entity

I.1) Name and addresses

NHS Wales Shared Services Partnership - Procurement Services

4-5 Charnwood Court,, Heol Billingsley, Parc Nantgarw

Cardiff

CF47 9DT

UK

Contact person: Marc Withers

Telephone: +44 1443848585

E-mail: marc.withers@wales.nhs.uk

NUTS: UK

Internet address(es)

Main address: http://nwssp.nhs.wales/ourservices/procurement-services/

Address of the buyer profile: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221

I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Blood glucose consumables and EQA materials

II.1.2) Main CPV code

33696200

 

II.1.3) Type of contract

Supplies

II.1.4) Short description

Supply of blood glucose consumables (testing strips) and EQA materials.

II.1.6) Information about lots

This contract is divided into lots: No

II.1.7) Total value of the procurement

Value excluding VAT: 237 488.02  GBP

II.2) Description

II.2.3) Place of performance

NUTS code:

UKL15


Main site or place of performance:

CTM UHB region

II.2.4) Description of the procurement

Blood glucose monitoring refers to testing the concentration of glucose in the blood to aid the management of Diabetes types 1 & 2.

Similarly, monitoring the presence of ketones in the blood is also important as high levels can result in complications such as Ketoacidosis.

This procurement will involve the supply of Blood glucose monitoring equipment(meters) and associated consumables (Test-strips for the

Point of Care Testing Service at Cwm Taf Morgannwg University Health Board. This will be to renew the

existing arrangement with Abbott Laboratories Ltd.

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Award of a contract without prior publication of a call for competition

Justification for selected award procedure:

The procurement falls outside the scope of application of the Directive

Explanation:

The current contract with Abbott Laboratories Ltd ended on the 30th of September 2021. The Health Board's intention was to enter into a new contract with Abbott Laboratories Ltd through a direct award under the terms of a Public Sector Framework.

This would enable sufficient time for NWSSP Shared Services Procurement to undertake a formal market-test exercise, to award a new All Wales Framework. Currently, the Health Board's POCT Service is not able to contemplate an alternative supplier for the reasons outlined

below:

The migration of operators to a completely new device would need to be completed on a rolling basis with full training for every member of staff. The POCT Team is not in a position to support this due to the extra training demands in relation to Covid-19 and the clinical areas are still finding it difficult to release staff to attend training, due to staffing pressures.

The current management of testing allows for staff to move flexibly from one area or site to another. During the process of migration, this flexibility will be lost to a degree with some areas using the new meter and other areas using the existing meter, this could expose the HB

to risk, given current staffing pressures.

The Health Board cannot find a Public Sector Framework with which to engage with Abbott Laboratories Ltd at this time and therefore, there is no opportunity to make a compliant direct award.

For the reasons outlined above and to ensure continuity of service for patient care, the Health Board has no option but to enter into a 12-month agreement without any formal underpinning Framework arrangement.

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No

Section V: Award of contract/concession

V.2 Award of contract/concession

V.2.1) Date of conclusion of the contract/concession

08/10/2021

V.2.2) Information about tenders

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Abbott Laboratories Ltd

Abbott House, Vanwall Business Park

Maidenhead

SL64XE

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the concession and main financing terms (excluding VAT)

Total value of the concession/lot: 237 488.02  GBP

V.2.5) Information about subcontracting

Section VI: Complementary information

VI.3) Additional information

NOTE: To register your interest in this notice and obtain any additional information please visit the Sell2Wales Web Site at https://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=115133.

(WA Ref:115133)

VI.4) Procedures for review

VI.4.1) Review body

High Court

Royal Courts of Justice, The Strand

London

WC2A 2LL

UK

Telephone: +44 2079477501

VI.5) Date of dispatch of this notice

22/10/2021

Coding

Commodity categories

ID Title Parent category
33696200 Blood-testing reagents Reagents and contrast media

Delivery locations

ID Description
1015 Central Valleys (Merthyr Tydfil, Rhondda Cynon Taf)

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
marc.withers@wales.nhs.uk
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.